AR086346A1 - Proceso para producir un material inorganico particulado - Google Patents

Proceso para producir un material inorganico particulado

Info

Publication number
AR086346A1
AR086346A1 ARP120101657A ARP120101657A AR086346A1 AR 086346 A1 AR086346 A1 AR 086346A1 AR P120101657 A ARP120101657 A AR P120101657A AR P120101657 A ARP120101657 A AR P120101657A AR 086346 A1 AR086346 A1 AR 086346A1
Authority
AR
Argentina
Prior art keywords
inorganic material
produce
particulated inorganic
particulated
particulate inorganic
Prior art date
Application number
ARP120101657A
Other languages
English (en)
Inventor
Maio Mario Dr
Eugenia Breininger
Cabrera Perez Karin Dra
Lang Ulrich Dr
Benjamin Peters
Thomas Puchert
Saal Christoph Dr
Michael Schulz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR086346A1 publication Critical patent/AR086346A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C01B33/141—Preparation of hydrosols or aqueous dispersions
    • C01B33/142—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates
    • C01B33/143—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates of aqueous solutions of silicates
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • C01B33/187—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates
    • C01B33/193—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates of aqueous solutions of silicates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Abstract

Proceso para producir un material inorgánico particulado, el material inorgánico particulado que puede obtenerse con dicho proceso, un sistema de administración con liberación modificada que comprende dicho material y el uso de dicho material en la administración de un agente bioactivo.
ARP120101657A 2011-05-13 2012-05-11 Proceso para producir un material inorganico particulado AR086346A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11003961 2011-05-13

Publications (1)

Publication Number Publication Date
AR086346A1 true AR086346A1 (es) 2013-12-04

Family

ID=46022158

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101657A AR086346A1 (es) 2011-05-13 2012-05-11 Proceso para producir un material inorganico particulado

Country Status (18)

Country Link
US (1) US9517268B2 (es)
EP (1) EP2707329B1 (es)
JP (1) JP6040497B2 (es)
KR (1) KR101906792B1 (es)
CN (1) CN103534208B (es)
AR (1) AR086346A1 (es)
AU (1) AU2012258092B2 (es)
BR (1) BR112013029149A2 (es)
CA (1) CA2836782A1 (es)
DK (1) DK2707329T3 (es)
EA (1) EA201301264A1 (es)
ES (1) ES2657822T3 (es)
IL (1) IL229209A (es)
MX (1) MX352176B (es)
PT (1) PT2707329T (es)
SG (1) SG194820A1 (es)
WO (1) WO2012156023A1 (es)
ZA (1) ZA201309469B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10577250B2 (en) 2011-05-13 2020-03-03 Merck Patent Gmbh Process for producing of inorganic particulate material
ES2728252T3 (es) * 2012-11-12 2019-10-23 Merck Patent Gmbh Uso de material a base de óxido de silicio para la liberación modificada de agentes biológicamente activos
KR20160089504A (ko) * 2013-11-26 2016-07-27 메르크 파텐트 게엠베하 무기 미립자 재료의 제조 방법
US11246931B2 (en) 2017-05-19 2022-02-15 Tokuyama Corporation Active pharmaceutical ingredient carrier and production method of the same
CN110133765A (zh) * 2018-02-08 2019-08-16 法国圣戈班玻璃厂 带有耐污层的光学组件及其制备方法和应用
JP7352936B2 (ja) * 2018-08-17 2023-09-29 地方独立行政法人東京都立産業技術研究センター 多孔質シリカ、機能材料および多孔質シリカの製造方法
WO2020127281A1 (en) 2018-12-20 2020-06-25 Merck Patent Gmbh A release system comprising a bioactive agent and a particulate material
WO2021220507A1 (ja) * 2020-05-01 2021-11-04 昭和電工マテリアルズ株式会社 多孔質体形成用塗液、多孔質体及び多孔質体の製造方法
JP6924338B1 (ja) * 2021-01-29 2021-08-25 三井金属鉱業株式会社 ゾル、ゲル及びシリカ多孔体を製造する装置及び方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070216A (en) 1964-03-09 1967-06-01 Grace W R & Co Improvements in or relating to silica and silica-alumina gels
JP3985170B2 (ja) * 1996-12-26 2007-10-03 直弘 曽我 無機系多孔質体の製造方法
JP3985171B2 (ja) 1996-12-26 2007-10-03 直弘 曽我 無機系多孔質体の製造方法
ATE225320T1 (de) * 1996-12-26 2002-10-15 Merck Patent Gmbh Anorganisches, poröses material und verfahren zu dessen herstellung
BR9807718A (pt) 1997-02-24 2000-02-15 Dow Corning Géis de sìlica hidrofóbica envelhecida neutra com área de superfìcie reduzida
EP1049929B1 (en) 1998-01-23 2009-08-19 MERCK PATENT GmbH Process for producing inorganic porous material in a capillary
JPH11292528A (ja) 1998-01-23 1999-10-26 Naohiro Soga 無機多孔質材料の製造法
CA2380941A1 (en) 1999-08-16 2001-02-22 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
DK1419106T3 (en) 2001-08-13 2017-01-30 Rhone Poulenc Chimie PROCEDURE FOR MANUFACTURING SILICA WITH SPECIFIC PARTICLE SIZE DISTRIBUTION AND / OR POR SIZE DISTRIBUTION
CN1777411B (zh) 2003-02-24 2013-01-02 药品生产公司 经粘膜药物递送系统
GB0315012D0 (en) 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
JP4519433B2 (ja) * 2003-09-17 2010-08-04 株式会社トクヤマ 微粒子状メソポーラスシリカ
EP1702886A4 (en) 2003-09-11 2011-02-16 Taiyo Kagaku Kk POROUS SILICA WHICH CARRYS A SUBSTANCE
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
US20070224133A1 (en) 2006-03-23 2007-09-27 Mcgill Patrick D High-cleaning silica materials made via product morphology control under high shear conditions
JP2009013142A (ja) * 2007-07-09 2009-01-22 Kyoto Univ 徐放用メソポーラスシリカ
CN101348713A (zh) 2007-07-20 2009-01-21 同济大学 能发射荧光的磁性复合纳米微球及其制备方法
CN101113247A (zh) 2007-09-05 2008-01-30 广州市飞雪化工有限公司 一种透明磨擦粒子的制备方法
CN101250313B (zh) * 2008-03-19 2010-12-08 中国科学院化学研究所 纳米粒子复合物及其制备方法
CN101343065A (zh) * 2008-09-04 2009-01-14 复旦大学 一种纳米二氧化硅空心球材料及其制备方法
CN101412517A (zh) 2008-11-14 2009-04-22 华东理工大学 孔径可控的介孔二氧化硅微球的制备方法及应用
JP5426869B2 (ja) * 2008-11-19 2014-02-26 パナソニック株式会社 メソポーラスシリカ微粒子の製造方法、メソポーラスシリカ微粒子含有組成物、及びメソポーラスシリカ微粒子含有成型物
JP4521477B1 (ja) * 2009-01-15 2010-08-11 水澤化学工業株式会社 非晶質シリカ
CN101559952A (zh) 2009-05-13 2009-10-21 南京工业大学 一种纳米尺度介孔二氧化硅球的制备方法
CN101829331A (zh) 2010-05-28 2010-09-15 沈阳药科大学 一种适用于难溶性药物的三维有序大孔二氧化硅给药体系

Also Published As

Publication number Publication date
AU2012258092A1 (en) 2014-01-09
KR101906792B1 (ko) 2018-10-11
JP2014522363A (ja) 2014-09-04
IL229209A (en) 2016-12-29
CA2836782A1 (en) 2012-11-22
IL229209A0 (en) 2014-01-30
SG194820A1 (en) 2013-12-30
EP2707329B1 (en) 2017-11-01
CN103534208B (zh) 2017-07-18
DK2707329T3 (en) 2018-01-15
ZA201309469B (en) 2014-08-27
KR20140033122A (ko) 2014-03-17
WO2012156023A8 (en) 2014-01-30
MX2013013135A (es) 2014-02-11
US9517268B2 (en) 2016-12-13
WO2012156023A1 (en) 2012-11-22
EA201301264A1 (ru) 2014-04-30
CN103534208A (zh) 2014-01-22
ES2657822T3 (es) 2018-03-07
US20140336274A1 (en) 2014-11-13
BR112013029149A2 (pt) 2017-02-07
JP6040497B2 (ja) 2016-12-07
EP2707329A1 (en) 2014-03-19
PT2707329T (pt) 2018-02-07
AU2012258092B2 (en) 2015-08-20
MX352176B (es) 2017-11-13

Similar Documents

Publication Publication Date Title
AR086346A1 (es) Proceso para producir un material inorganico particulado
DOP2013000250A (es) Composiciones de nucleasa terapeuticas y metodos
CL2014001070A1 (es) Compuestos derivados de aminoácidos funcionalizados en el n-terminal, capaces de formar micro- o nanopartículas para encapsular un agente; composición; uso para tratar enfermedades; y método de suministro de un polinucleótido a una célula.
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
CL2015002802A1 (es) Composiciones y métodos para producir cetosis elevada y sostenida
ECSP15004752A (es) Formulaciones de etanercept que muestran una marcada reducción de la cantidad de partículas subvisibles
AR091733A1 (es) Proceso para producir minerales que contienen carbonato de calcio de superficie modificada
CL2012002698A1 (es) Artículo para fumar que comprende un sistema de flujo variable configurado para controlar de forma variable el flujo gaseoso en o a través del artículo para fumar.
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
AR093411A1 (es) Metodos para formar y colocar pilares de soporte en una formacion subterranea
AR098996A1 (es) Formulación compuesta para la administración por vía oral que comprende ezetimiba y rosuvastatina
BR112016012759A8 (pt) sistema de distribuição de sabor para tabaco, composição e artigo para fumar, método de formação da referida composição e uso de um sistema de distribuição de sabor
NI201500118A (es) Imidazopiridazinas sustituidas
BR112014017481A8 (pt) formulação em pó seco para uso em um inalador de pó seco, inalador de pó seco e uso de uma formulação
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
AR098129A1 (es) Preparación y administración de soluciones de liberación sostenida de óxido nítrico
CL2013003198A1 (es) Uso de volasertib, una sal o un hidrato del mismo para preparar un medicamento útil en el tratamiento de malignidades sólidas que incluyen malignidades sólidas avanzadas y metastásicas.
PH12014502834A1 (en) Pharmaceutical form for extended release of active substances
MX2016006738A (es) Procedimiento para producir material particulado inorganico.
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
AR090725A1 (es) Metodos para producir clorhidrato de anamorelina que tiene contenido controlado de cloruro
BR112017014083A2 (pt) artigos abrasivos e métodos para formar os mesmos
HRP20130082A2 (hr) Farmaceutski pripravak za produljeno oslobađanje trimetazidina
TWD166399S (zh) 飲料分配器之部分
CL2015001921A1 (es) Formulaciones de lorazepam de liberación controlada

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FG Grant, registration